Inventionmed (WAR:INM) DeferredTaxAndRevenue: zł0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:INM Inventionmed SA WAR:INM
19 GF Score
Price zł0.10
! 7 Warning Signs
View Full Analysis

What is Inventionmed DeferredTaxAndRevenue?

Inventionmed WAR:INM +2.45% 19 DeferredTaxAndRevenue is zł0.00 Mil as of Mar. 2026. GuruFocus rates WAR:INM with a GF Score™ of 19/100. The stock has 7 warning signs investors should review.

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Inventionmed's current deferred tax and revenue for the quarter that ended in Mar. 2026 was zł0.00 Mil.

Inventionmed DeferredTaxAndRevenue Related Terms

Inventionmed DeferredTaxAndRevenue Historical Data

* Premium members only.

The historical data trend for Inventionmed's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inventionmed DeferredTaxAndRevenue Chart

Inventionmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
DeferredTaxAndRevenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Inventionmed Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
DeferredTaxAndRevenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:INM
19GF Score
Inventionmed SA WAR:INM
DeferredTaxAndRevenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about DeferredTaxAndRevenue →
What does a DeferredTaxAndRevenue of zł0.00 Mil mean?
Inventionmed (WAR:INM) has a DeferredTaxAndRevenue of zł0.00 Mil as of Mar. 2026. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Inventionmed.
Is Inventionmed's DeferredTaxAndRevenue too high?
Inventionmed's current DeferredTaxAndRevenue is zł0.00 Mil. Overall, Inventionmed has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Inventionmed's DeferredTaxAndRevenue compare to ABT and SYK?
Inventionmed's DeferredTaxAndRevenue of zł0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good DeferredTaxAndRevenue for a Medical Devices & Instruments company?
A good DeferredTaxAndRevenue depends on the Medical Devices & Instruments industry context. However, DeferredTaxAndRevenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high DeferredTaxAndRevenue mean?
A high DeferredTaxAndRevenue can signal that a stock is expensive relative to its fundamentals. Deferred tax and revenue represents the current portion of taxes and unearned revenue that are now past due. View historical data on Inventionmed. Inventionmed's current DeferredTaxAndRevenue is zł0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inventionmed stock overvalued right now?
Inventionmed (WAR:INM) has a current DeferredTaxAndRevenue of zł0.00 Mil. The current DeferredTaxAndRevenue is zł0.00 Mil. Inventionmed's overall GF Score™ is 19/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is DeferredTaxAndRevenue calculated?
DeferredTaxAndRevenue is calculated from a company's financial statements. For Inventionmed (WAR:INM), the current DeferredTaxAndRevenue is zł0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inventionmed Business Description

Address Jana Zamoyskiego 2B Street, Bydgoszcz, POL, 85-063
Inventionmed SA focuses on the development of medical simulators based on VR technology for use in education in esthetic and clinical dermatology. The company's project consists of TutorDerm, Double immersion, Virtual Syringe, and others.
19GF Score

Get the complete analysis for WAR:INM

DeferredTaxAndRevenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.10
Price